338 related articles for article (PubMed ID: 25808652)
21. Aflibercept: A Review in Metastatic Colorectal Cancer.
Syed YY; McKeage K
Drugs; 2015 Aug; 75(12):1435-45. PubMed ID: 26220913
[TBL] [Abstract][Full Text] [Related]
22. Targeting Angiogenesis in Colorectal Cancer: Tyrosine Kinase Inhibitors.
Kircher SM; Nimeiri HS; Benson AB
Cancer J; 2016; 22(3):182-9. PubMed ID: 27341596
[TBL] [Abstract][Full Text] [Related]
23. Ziv-aflibercept: binding to more than VEGF-A--does more matter?
Clarke JM; Hurwitz HI
Nat Rev Clin Oncol; 2013 Jan; 10(1):10-1. PubMed ID: 23149898
[TBL] [Abstract][Full Text] [Related]
24. Regorafenib in metastatic colorectal cancer.
Sartore-Bianchi A; Zeppellini A; Amatu A; Ricotta R; Bencardino K; Siena S
Expert Rev Anticancer Ther; 2014 Mar; 14(3):255-65. PubMed ID: 24559322
[TBL] [Abstract][Full Text] [Related]
25. Regorafenib induces adaptive resistance of colorectal cancer cells via inhibition of vascular endothelial growth factor receptor.
Tomida C; Nagano H; Yamagishi N; Uchida T; Ohno A; Hirasaka K; Nikawa T; Teshima-Kondo S
J Med Invest; 2017; 64(3.4):262-265. PubMed ID: 28954993
[TBL] [Abstract][Full Text] [Related]
26. Angiogenesis inhibition in the second-line treatment of metastatic colorectal cancer: A systematic review and pooled analysis.
Chebib R; Verlingue L; Cozic N; Faron M; Burtin P; Boige V; Hollebecque A; Malka D
Semin Oncol; 2017 Apr; 44(2):114-128. PubMed ID: 28923209
[TBL] [Abstract][Full Text] [Related]
27. An overview of experimental and investigational multikinase inhibitors for the treatment of metastatic colorectal cancer.
Lee YC; Michael M; Zalcberg JR
Expert Opin Investig Drugs; 2015; 24(10):1307-20. PubMed ID: 26212373
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of aflibercept in the treatment of metastatic colorectal cancer.
Macarulla T; Sauri T; Tabernero J
Expert Opin Biol Ther; 2014 Oct; 14(10):1493-505. PubMed ID: 25152076
[TBL] [Abstract][Full Text] [Related]
29. Molecular insight of regorafenib treatment for colorectal cancer.
Arai H; Battaglin F; Wang J; Lo JH; Soni S; Zhang W; Lenz HJ
Cancer Treat Rev; 2019 Dec; 81():101912. PubMed ID: 31715423
[TBL] [Abstract][Full Text] [Related]
30. The evolving role of VEGF-targeted therapies in the treatment of metastatic colorectal cancer.
Fakih M
Expert Rev Anticancer Ther; 2013 Apr; 13(4):427-38. PubMed ID: 23432698
[TBL] [Abstract][Full Text] [Related]
31. Novel anti-angiogenic therapeutic strategies in colorectal cancer.
Tampellini M; Sonetto C; Scagliotti GV
Expert Opin Investig Drugs; 2016; 25(5):507-20. PubMed ID: 26938715
[TBL] [Abstract][Full Text] [Related]
32. Antiangiogenesis therapy in second line metastatic colorectal cancer: similar but different.
Saif MW
Expert Opin Biol Ther; 2013 Nov; 13(11):1489-93. PubMed ID: 24050123
[TBL] [Abstract][Full Text] [Related]
33. Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients.
Giampieri R; Salvatore L; Del Prete M; Prochilo T; D'Anzeo M; Loretelli C; Loupakis F; Aprile G; Maccaroni E; Andrikou K; Bianconi M; Bittoni A; Faloppi L; Demurtas L; Montironi R; Scarpelli M; Falcone A; Zaniboni A; Scartozzi M; Cascinu S
Sci Rep; 2016 Apr; 6():25195. PubMed ID: 27117754
[TBL] [Abstract][Full Text] [Related]
34. The role of tumor angiogenesis as a therapeutic target in colorectal cancer.
Battaglin F; Puccini A; Intini R; Schirripa M; Ferro A; Bergamo F; Lonardi S; Zagonel V; Lenz HJ; Loupakis F
Expert Rev Anticancer Ther; 2018 Mar; 18(3):251-266. PubMed ID: 29338550
[TBL] [Abstract][Full Text] [Related]
35. Current and advancing treatments for metastatic colorectal cancer.
Sanz-Garcia E; Grasselli J; Argiles G; Elez ME; Tabernero J
Expert Opin Biol Ther; 2016; 16(1):93-110. PubMed ID: 26549053
[TBL] [Abstract][Full Text] [Related]
36. Targeting Angiogenesis in Colorectal Carcinoma.
Lopez A; Harada K; Vasilakopoulou M; Shanbhag N; Ajani JA
Drugs; 2019 Jan; 79(1):63-74. PubMed ID: 30617958
[TBL] [Abstract][Full Text] [Related]
37. Antiangiogenic Therapy in Colorectal Cancer.
Mody K; Baldeo C; Bekaii-Saab T
Cancer J; 2018; 24(4):165-170. PubMed ID: 30119079
[TBL] [Abstract][Full Text] [Related]
38. Regorafenib in the treatment of colorectal cancer.
Majithia N; Grothey A
Expert Opin Pharmacother; 2016; 17(1):137-45. PubMed ID: 26559195
[TBL] [Abstract][Full Text] [Related]
39. Regorafenib: A Review in Metastatic Colorectal Cancer.
Dhillon S
Drugs; 2018 Jul; 78(11):1133-1144. PubMed ID: 29943375
[TBL] [Abstract][Full Text] [Related]
40. [Aflibercept (Zaltrap(®)) approved in metastatic colorectal cancer].
André T; Chibaudel B
Bull Cancer; 2013 Oct; 100(10):1023-5. PubMed ID: 24047539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
